Skip to content
ALB

ALBEMARLE CORP

ALBEMARLE CORP Q4 FY2024 earnings call

February 13, 2025 · fiscal period ended 2024-12

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2025-02-13

Management highlights

Albemarle is acting decisively in four key areas: optimizing the global conversion network, improving cost and efficiency, reducing capital expenditure, and enhancing financial flexibility. The company announced placing the Chengdu lithium conversion facility into care and maintenance by mid-2025 and shifting capacity at the Qinzhou lithium conversion facility from hydroxide to carbonate. For 2025, the CapEx outlook has been further decreased by $100 million, now expected to be in the range of $700 million to $800 million. Albemarle has line of sight to achieve breakeven free cash flow in 2025, thanks to ongoing efforts to enhance productivity, reduce costs, and other cash conversion enhancements. The company is also seeing benefits from nonmanufacturing cost improvements and changes in its operating structure.

View in transcript ↓

Segment performance

In the fourth quarter, net sales were $1.2 billion and adjusted EBITDA was $251 million. For the full year 2024, net sales totaled $5.4 billion and adjusted EBITDA reached $1.1 billion. The Energy Storage segment saw a 26% year-over-year increase in sales volumes, surpassing the initial guidance of 10% to 20% growth. Fourth quarter adjusted EBITDA improvement was driven by higher volumes, productivity enhancements, and lower cost of goods sold across all business segments. The Energy Storage segment contributed significantly to the year-over-year EBITDA growth, with its sales volumes growing robustly.

View in transcript ↓

Guidance

Albemarle provides outlook based on ranges of lithium market prices, including $9 per kilogram, $12 to $15 per kilogram, and $20 per kilogram scenarios. For 2025, the company expects Energy Storage volumes to be slightly higher year-over-year. Specialties is foreseen to have a modest volume-led recovery driven by strength in pharma, autos, and oilfield applications. Ketjen is expected to see modest improvements related to product mix, cost, and productivity improvements. The 2025 CapEx is expected to be in the range of $700 million to $800 million, a decrease from 2024, and the company has line of sight to breakeven free cash flow in 2025.

View in transcript ↓

Risks

The lithium market is subject to supply-demand dynamics with announced curtailments both upstream and downstream. A significant portion of the global resource cost curve is at or below breakeven, posing pressure on the market. Nonintegrated hard rock conversion remains unprofitable, and larger integrated producers face challenges.

View in transcript ↓

Q&A highlights

Q: On the contract mix, should we assume most of the remaining 50% follow spot mechanisms?

A: Yes, the other 50% is pretty much at index.

Q: Could Albemarle's actions including cutting CapEx and placing Chengdu under care and maintenance influence the broader market?

A: No, it's due to market conditions and product mix, and Chengdu is one of the smallest facilities, so unlikely to influence the market much.

Q: Explanation of the wide range in the tax guide for 2025?

A: Driven by the variety of scenarios and tax valuation allowances in certain jurisdictions like China and Australia where tax evaluation allowances were taken

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

February 13, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.